Alimera Completes Recruitment for the Synchronicity Study
About 67% of Alimera Sciences' investor base is looking to short. The analysis of current outlook of investing in Alimera Sciences suggests that many traders are alarmed regarding Alimera Sciences' prospects. Alimera Sciences' investing sentiment overview a quick insight into current market opportunities from investing in Alimera Sciences. Many technical investors use Alimera Sciences stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Alimera |
Study with YUTIQ has Surpassed Goal of 100 Patients EnrolledATLANTA, Jan. 04, 2024 -- Alimera Sciences, Inc. , a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, today announces that it has completed enrollment for the companys Synchronicity Study, a prospective, open-label clinical study evaluating the safety and efficacy of YUTIQ
Read at finance.yahoo.com
![]() |
Alimera Sciences Fundamental Analysis
We analyze Alimera Sciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alimera Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alimera Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Shares Shorted
Number Of Shares Shorted Comparative Analysis
Alimera Sciences is currently under evaluation in number of shares shorted category among its peers. Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
Alimera Sciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Alimera Sciences stock to make a market-neutral strategy. Peer analysis of Alimera Sciences could also be used in its relative valuation, which is a method of valuing Alimera Sciences by comparing valuation metrics with similar companies.
Peers
Alimera Sciences Related Equities
PTPI | Petros Pharmaceuticals | 33.43 | ||||
DERM | Journey Medical | 21.27 | ||||
CPHI | China Pharma | 1.35 | ||||
ORGO | Organogenesis Holdings | 0.66 | ||||
LFCR | Lifecore Biomedical | 0.60 | ||||
SXTC | China SXT | 1.20 | ||||
SHPH | Shuttle Pharmaceuticals | 4.61 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in Alimera Stock
If you are still planning to invest in Alimera Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Alimera Sciences' history and understand the potential risks before investing.
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |